Selected research
Industry Research
Tong Mai Granule Industry Research Report 2026
Market perspective
The global Tong Mai Granule market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tong Mai Granule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tong Mai Granule is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Tong Mai Granule is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tong Mai Granule include Jilin Galaxy Pharmaceutical, Ykpharm, Xuyang Pharm, Xiuzheng Group, Taiji Group, Shineway, Shenqi Pharmaceutical, Mintai Pharmaceutical and Luyinyaoye, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tong Mai Granule market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tong Mai Granule Market by Company
Jilin Galaxy Pharmaceutical
Ykpharm
Xuyang Pharm
Xiuzheng Group
Taiji Group
Shineway
Shenqi Pharmaceutical
Mintai Pharmaceutical
Luyinyaoye
Sunflower Group
Jiuzhitang
Jiulong Pharmaceutical
Jianjin Pharmaceutical
Henan Xingyuan Pharmaceutical
Wansuiyaoye
Holyshine Pharmaceutical
Guizhou Bailing Group Pharmaceutical
Gansu Minhai Pharmaceutical
Sichuan Fengchun Pharmaceutical
Dayang Pharmaceutical
Tong Mai Granule Segment by Type
Sugar Free
Sugary
Tong Mai Granule Segment by Application
Hospital
Clinic
Pharmacy
Tong Mai Granule Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tong Mai Granule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tong Mai Granule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tong Mai Granule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tong Mai Granule manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tong Mai Granule by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tong Mai Granule in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Sugar Free
- Sugary
Applications
- Hospital
- Clinic
- Pharmacy
Companies covered
- Jilin Galaxy Pharmaceutical
- Ykpharm
- Xuyang Pharm
- Xiuzheng Group
- Taiji Group
- Shineway
- Shenqi Pharmaceutical
- Mintai Pharmaceutical
- Luyinyaoye
- Sunflower Group
- Jiuzhitang
- Jiulong Pharmaceutical
- Jianjin Pharmaceutical
- Henan Xingyuan Pharmaceutical
- Wansuiyaoye
- Holyshine Pharmaceutical
- Guizhou Bailing Group Pharmaceutical
- Gansu Minhai Pharmaceutical
- Sichuan Fengchun Pharmaceutical
- Dayang Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tong Mai Granule Market Size (2021-2032)
- 2.2.2 Global Tong Mai Granule Sales (2021-2032)
- 2.2.3 Global Tong Mai Granule Market Average Price (2021-2032)
- 2.3 Tong Mai Granule by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Sugar Free
- 2.3.3 Sugary
- 2.4 Tong Mai Granule by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tong Mai Granule Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tong Mai Granule Sales (units) of Manufacturers (2021-2026)
- 3.3 Global Tong Mai Granule Revenue of Manufacturers (2021-2026)
- 3.4 Global Tong Mai Granule Average Price by Manufacturers (2021-2026)
- 3.5 Global Tong Mai Granule Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tong Mai Granule, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tong Mai Granule, Product Type & Application
- 3.8 Global Manufacturers of Tong Mai Granule, Established Date
- 3.9 Global Tong Mai Granule Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Jilin Galaxy Pharmaceutical
- 4.1.1 Jilin Galaxy Pharmaceutical Company Information
- 4.1.2 Jilin Galaxy Pharmaceutical Business Overview
- 4.1.3 Jilin Galaxy Pharmaceutical Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Jilin Galaxy Pharmaceutical Tong Mai Granule Product Portfolio
- 4.1.5 Jilin Galaxy Pharmaceutical Recent Developments
- 4.2 Ykpharm
- 4.2.1 Ykpharm Company Information
- 4.2.2 Ykpharm Business Overview
- 4.2.3 Ykpharm Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Ykpharm Tong Mai Granule Product Portfolio
- 4.2.5 Ykpharm Recent Developments
- 4.3 Xuyang Pharm
- 4.3.1 Xuyang Pharm Company Information
- 4.3.2 Xuyang Pharm Business Overview
- 4.3.3 Xuyang Pharm Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Xuyang Pharm Tong Mai Granule Product Portfolio
- 4.3.5 Xuyang Pharm Recent Developments
- 4.4 Xiuzheng Group
- 4.4.1 Xiuzheng Group Company Information
- 4.4.2 Xiuzheng Group Business Overview
- 4.4.3 Xiuzheng Group Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Xiuzheng Group Tong Mai Granule Product Portfolio
- 4.4.5 Xiuzheng Group Recent Developments
- 4.5 Taiji Group
- 4.5.1 Taiji Group Company Information
- 4.5.2 Taiji Group Business Overview
- 4.5.3 Taiji Group Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Taiji Group Tong Mai Granule Product Portfolio
- 4.5.5 Taiji Group Recent Developments
- 4.6 Shineway
- 4.6.1 Shineway Company Information
- 4.6.2 Shineway Business Overview
- 4.6.3 Shineway Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shineway Tong Mai Granule Product Portfolio
- 4.6.5 Shineway Recent Developments
- 4.7 Shenqi Pharmaceutical
- 4.7.1 Shenqi Pharmaceutical Company Information
- 4.7.2 Shenqi Pharmaceutical Business Overview
- 4.7.3 Shenqi Pharmaceutical Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shenqi Pharmaceutical Tong Mai Granule Product Portfolio
- 4.7.5 Shenqi Pharmaceutical Recent Developments
- 4.8 Mintai Pharmaceutical
- 4.8.1 Mintai Pharmaceutical Company Information
- 4.8.2 Mintai Pharmaceutical Business Overview
- 4.8.3 Mintai Pharmaceutical Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mintai Pharmaceutical Tong Mai Granule Product Portfolio
- 4.8.5 Mintai Pharmaceutical Recent Developments
- 4.9 Luyinyaoye
- 4.9.1 Luyinyaoye Company Information
- 4.9.2 Luyinyaoye Business Overview
- 4.9.3 Luyinyaoye Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Luyinyaoye Tong Mai Granule Product Portfolio
- 4.9.5 Luyinyaoye Recent Developments
- 4.10 Sunflower Group
- 4.10.1 Sunflower Group Company Information
- 4.10.2 Sunflower Group Business Overview
- 4.10.3 Sunflower Group Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sunflower Group Tong Mai Granule Product Portfolio
- 4.10.5 Sunflower Group Recent Developments
- 4.11 Jiuzhitang
- 4.11.1 Jiuzhitang Company Information
- 4.11.2 Jiuzhitang Business Overview
- 4.11.3 Jiuzhitang Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Jiuzhitang Tong Mai Granule Product Portfolio
- 4.11.5 Jiuzhitang Recent Developments
- 4.12 Jiulong Pharmaceutical
- 4.12.1 Jiulong Pharmaceutical Company Information
- 4.12.2 Jiulong Pharmaceutical Business Overview
- 4.12.3 Jiulong Pharmaceutical Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Jiulong Pharmaceutical Tong Mai Granule Product Portfolio
- 4.12.5 Jiulong Pharmaceutical Recent Developments
- 4.13 Jianjin Pharmaceutical
- 4.13.1 Jianjin Pharmaceutical Company Information
- 4.13.2 Jianjin Pharmaceutical Business Overview
- 4.13.3 Jianjin Pharmaceutical Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Jianjin Pharmaceutical Tong Mai Granule Product Portfolio
- 4.13.5 Jianjin Pharmaceutical Recent Developments
- 4.14 Henan Xingyuan Pharmaceutical
- 4.14.1 Henan Xingyuan Pharmaceutical Company Information
- 4.14.2 Henan Xingyuan Pharmaceutical Business Overview
- 4.14.3 Henan Xingyuan Pharmaceutical Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Henan Xingyuan Pharmaceutical Tong Mai Granule Product Portfolio
- 4.14.5 Henan Xingyuan Pharmaceutical Recent Developments
- 4.15 Wansuiyaoye
- 4.15.1 Wansuiyaoye Company Information
- 4.15.2 Wansuiyaoye Business Overview
- 4.15.3 Wansuiyaoye Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Wansuiyaoye Tong Mai Granule Product Portfolio
- 4.15.5 Wansuiyaoye Recent Developments
- 4.16 Holyshine Pharmaceutical
- 4.16.1 Holyshine Pharmaceutical Company Information
- 4.16.2 Holyshine Pharmaceutical Business Overview
- 4.16.3 Holyshine Pharmaceutical Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Holyshine Pharmaceutical Tong Mai Granule Product Portfolio
- 4.16.5 Holyshine Pharmaceutical Recent Developments
- 4.17 Guizhou Bailing Group Pharmaceutical
- 4.17.1 Guizhou Bailing Group Pharmaceutical Company Information
- 4.17.2 Guizhou Bailing Group Pharmaceutical Business Overview
- 4.17.3 Guizhou Bailing Group Pharmaceutical Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Guizhou Bailing Group Pharmaceutical Tong Mai Granule Product Portfolio
- 4.17.5 Guizhou Bailing Group Pharmaceutical Recent Developments
- 4.18 Gansu Minhai Pharmaceutical
- 4.18.1 Gansu Minhai Pharmaceutical Company Information
- 4.18.2 Gansu Minhai Pharmaceutical Business Overview
- 4.18.3 Gansu Minhai Pharmaceutical Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Gansu Minhai Pharmaceutical Tong Mai Granule Product Portfolio
- 4.18.5 Gansu Minhai Pharmaceutical Recent Developments
- 4.19 Sichuan Fengchun Pharmaceutical
- 4.19.1 Sichuan Fengchun Pharmaceutical Company Information
- 4.19.2 Sichuan Fengchun Pharmaceutical Business Overview
- 4.19.3 Sichuan Fengchun Pharmaceutical Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Sichuan Fengchun Pharmaceutical Tong Mai Granule Product Portfolio
- 4.19.5 Sichuan Fengchun Pharmaceutical Recent Developments
- 4.20 Dayang Pharmaceutical
- 4.20.1 Dayang Pharmaceutical Company Information
- 4.20.2 Dayang Pharmaceutical Business Overview
- 4.20.3 Dayang Pharmaceutical Tong Mai Granule Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Dayang Pharmaceutical Tong Mai Granule Product Portfolio
- 4.20.5 Dayang Pharmaceutical Recent Developments
5 Global Tong Mai Granule Market Scenario by Region
- 5.1 Global Tong Mai Granule Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tong Mai Granule Sales by Region: 2021-2032
- 5.2.1 Global Tong Mai Granule Sales by Region: 2021-2026
- 5.2.2 Global Tong Mai Granule Sales by Region: 2027-2032
- 5.3 Global Tong Mai Granule Revenue by Region: 2021-2032
- 5.3.1 Global Tong Mai Granule Revenue by Region: 2021-2026
- 5.3.2 Global Tong Mai Granule Revenue by Region: 2027-2032
- 5.4 North America Tong Mai Granule Market Facts & Figures by Country
- 5.4.1 North America Tong Mai Granule Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tong Mai Granule Sales by Country (2021-2032)
- 5.4.3 North America Tong Mai Granule Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Tong Mai Granule Market Facts & Figures by Country
- 5.5.1 Europe Tong Mai Granule Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tong Mai Granule Sales by Country (2021-2032)
- 5.5.3 Europe Tong Mai Granule Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Tong Mai Granule Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tong Mai Granule Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tong Mai Granule Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tong Mai Granule Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tong Mai Granule Market Facts & Figures by Country
- 5.7.1 South America Tong Mai Granule Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tong Mai Granule Sales by Country (2021-2032)
- 5.7.3 South America Tong Mai Granule Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Tong Mai Granule Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tong Mai Granule Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tong Mai Granule Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tong Mai Granule Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Tong Mai Granule Sales by Type (2021-2032)
- 6.1.1 Global Tong Mai Granule Sales by Type (2021-2032) & (units)
- 6.1.2 Global Tong Mai Granule Sales Market Share by Type (2021-2032)
- 6.2 Global Tong Mai Granule Revenue by Type (2021-2032)
- 6.2.1 Global Tong Mai Granule Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tong Mai Granule Revenue Market Share by Type (2021-2032)
- 6.3 Global Tong Mai Granule Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tong Mai Granule Sales by Application (2021-2032)
- 7.1.1 Global Tong Mai Granule Sales by Application (2021-2032) & (units)
- 7.1.2 Global Tong Mai Granule Sales Market Share by Application (2021-2032)
- 7.2 Global Tong Mai Granule Revenue by Application (2021-2032)
- 7.2.1 Global Tong Mai Granule Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tong Mai Granule Revenue Market Share by Application (2021-2032)
- 7.3 Global Tong Mai Granule Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tong Mai Granule Value Chain Analysis
- 8.1.1 Tong Mai Granule Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tong Mai Granule Production Mode & Process
- 8.2 Tong Mai Granule Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tong Mai Granule Distributors
- 8.2.3 Tong Mai Granule Customers
9 Global Tong Mai Granule Analyzing Market Dynamics
- 9.1 Tong Mai Granule Industry Trends
- 9.2 Tong Mai Granule Industry Drivers
- 9.3 Tong Mai Granule Industry Opportunities and Challenges
- 9.4 Tong Mai Granule Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst